Established in 1999, Prolacta Bioscience is a privately held life sciences company that has touched the lives of more than 70,000 premature infants globally.1
Dedicated to advancing the science of human milk, we employ more than 300 people throughout the world, many of whom have dedicated their lives to neonatal care. Together, we’re just as committed to ethical business practices, protecting the safety of our team, and fostering an inclusive culture.
Prolacta is the world’s leading hospital provider of 100% human milk–based nutritional products. Available to hospitals since 2006, our fortifiers changed the standard of care for extremely premature infants worldwide and are the first nutritional fortifiers made from 100% donor milk instead of cow milk.
We are also exploring the benefits of human milk including applications for infants who need surgery for congenital cardiac and gastrointestinal disorders.
David Steinberg, CFO